Industrifonden Investment Portfolio and Exits

Industrifonden has a strong track record of investment and exit success. The fund has made a significant number of investments in various industries, resulting in a diverse portfolio.

One notable investment is in the company Almi Invest, which is a major player in the Swedish venture capital market. Industrifonden has also invested in companies like Nordic Capital, a leading private equity firm.

Industrifonden's investment strategy focuses on supporting growth-oriented companies in Sweden and the Baltic region. The fund's investments are often in companies that are looking to expand their operations or enter new markets.

The fund's portfolio includes a mix of early-stage and growth-stage companies, each with its own unique characteristics and growth potential.

Industrifonden is a Swedish venture capital firm that has been investing in promising startups since 1989. They have a strong focus on technology and growth.

With over $1.5 billion in assets under management, Industrifonden has the resources to support ambitious entrepreneurs. They have a team of experienced investment professionals who work closely with portfolio companies to help them grow.

Industrifonden is also a member of the European Venture Capital Association (EVCA), which demonstrates their commitment to the venture capital industry.

Industrifonden is one of Sweden's largest and most experienced venture capital investors in early-stage growth companies.

They invest in small and medium-sized Swedish growth companies, taking a long-term approach to generate a return.

Industrifonden works on a commercial basis in partnership with entrepreneurs and other investors, which means they aim to make a profit while supporting the growth of new companies.

The company reinvests all capital in new companies, which helps to strengthen the Swedish venture capital market.

Industrifonden wants to be an innovative investor that creates lasting value, which suggests they're committed to making a positive impact.

Here's a brief overview of the cookies used by Industrifonden:

Peter Wolpert has been appointed the new CEO of Industrifonden, a position he will take up in March 2022.

He brings over 20 years of experience in company development, having served as CEO, strategy consultant, and board member.

Peter has an impressive track record, having founded Moberg Pharma AB (publ) in 2006, which reached close to half a billion SEK in revenue worldwide before its commercial portfolio was divested in 2019.

He has also been based in the US for the past few years, where he has been chairman of the board of Moberg Pharma AB (publ) and advisor to A3P Biomedical AB and OncoZenge AB (publ).

Peter has an MSc in Engineering Physics from the Royal Institute of Technology (KTH) and an MSc in Economics from the Stockholm School of Economics.

He is a strong leader and team builder with extensive experience in both corporate financing and commercial negotiations.

Industrifonden is an independent foundation with 6 billion SEK under management that invests in early- and growth-stage companies in deep tech, life science, and transformative tech.

The board has appointed Per Anell, Senior Investment Director at Industrifonden, as acting CEO until Peter Wolpert takes office in March 2022.

Industrifonden has made a total of 404 investments.

Their latest investment was in Gesynta Pharma as part of their Series D on January 20, 2025.

Industrifonden is also investing in Actiwave, a spin-off from research at Linköping University, which is developing a technology to improve sound quality in small speakers.

The investment in Actiwave totals SEK 13 million, which will be used for a market launch.

Industrifonden and Investinor are investing a combined SEK 79 million in Pharmalink, a specialty pharma company that improves and refines existing drugs.

Industrifonden has made a significant number of investments, with a total of 404 investments under their belt.

Their latest investment was a notable one, with Industrifonden investing in Gesynta Pharma as part of their Series D on January 20, 2025.

Industrifonden has a notable track record of successful portfolio exits. They have 71 portfolio exits in total.

Their latest portfolio exit was Combinostics, which was acquired by SyntheticMR on November 28, 2024. This acquisition was valued at $XXM.

Industrifonden's portfolio exits include a range of companies, from Combinostics to DPOrganizer. These companies have been acquired by various acquirers, such as SyntheticMR and DataGuard.

Here are some key statistics on Industrifonden's portfolio exits:

Industrifonden has made several strategic investments over the years, with a notable focus on acquisitions.

Their latest acquisition was Svensk Flygambulan on May 16, 2009, with a valuation of $XXM.

Industrifonden acquired a company in 1992, with a Series A investment stage.

Here are the details of their four acquisitions:

Pharmalink, a specialty pharma company, has raised SEK 96 million in a share issue led by Industrifonden and Investinor.

The investment will be used for the further development of Pharmalink's product portfolio. This includes clinical studies of Nefecon, a treatment for nephritis, and Busulipo, a treatment for bone marrow transplantation.

Industrifonden and Investinor of Norway are investing a combined SEK 79 million in Pharmalink. Private investors are also participating in the share issue.

Pharmalink is a company that improves and refines existing drugs. Its current projects are Nefecon and Busulipo.

Industrifonden's portfolio companies have had a significant impact on the Swedish economy. They have created thousands of jobs and generated billions of kronor in revenue.

One notable example is Spotify, which was a portfolio company of Industrifonden. Spotify is a global music streaming service that has revolutionized the way people listen to music. It was founded in 2006 and has since become one of the most popular music streaming services in the world.

Industrifonden's investment in Spotify was a strategic move to support the development of the company. This investment helped Spotify to grow and expand its operations, ultimately leading to its success.

Accedo's exit generated a 7x return on investment for Industrifonden, a Sweden-based venture capital investor.

This impressive return is a testament to the company's rapid growth, with Accedo being named one of Sweden's fastest growing companies in recent years.

Accedo has a significant global presence, with over 100 million users and 400 employees worldwide.

The company's TV and video solutions are used by hundreds of millions of people globally, making it a leader in its industry.

Accedo's revenue reached SEK 320 million, or approximately $40 million, demonstrating its financial stability and success.

Anyfi Networks is a company that's developing a technology for wireless Wi-Fi networks, allowing users to access their home networks from anywhere.

Industrifonden invested SEK 9 million in Anyfi Networks, with the current owners also participating in the new share issue, which totals SEK 10 million.

The money will be used for expansion and marketing, helping the company grow and reach more customers.

Anyfi Networks' technology enables operators to provide a secure and automatic connection to the end customer's home network, regardless of their location.

No installation is required in the user's phone or device, making it a convenient solution for users on-the-go.

Industrifonden is a Swedish venture capital firm that focuses on investing in growth-stage companies in the Nordic region. They have a strong track record of investing in successful startups.

Industrifonden has a dedicated team that works closely with entrepreneurs to identify and invest in promising companies. One of their notable investments is in the company Spotify, which was a successful exit.

Industrifonden's investment strategy is focused on supporting companies that have the potential to scale and become market leaders in their respective industries. They typically invest between 10-30 million euros in each company.

Annual revenue is a crucial metric for businesses to track, and it's defined as the total income earned by a company over a specific period of time, usually a year.

For example, Industrifonden, a Swedish investment company, reported an annual revenue of $6 million in 2025.

Annual revenue can fluctuate from year to year, depending on various factors such as market conditions and company performance.

Industrifonden's annual revenue is a significant amount for a company of its size, indicating a stable financial foundation.

Understanding annual revenue is essential for investors, creditors, and business owners to make informed decisions about a company's financial health and growth potential.

The annual revenue of Industrifonden serves as a benchmark for its financial performance, giving insight into its ability to generate income and sustain itself in the market.

Industrifonden is a Swedish venture capital company that employs a relatively small team of professionals. 33 people are employed at Industrifonden.

Their team size is a testament to their focus on supporting and guiding entrepreneurs rather than having a large, bureaucratic organization.

NAICS, or the North American Industry Classification System, is a powerful tool for businesses. It's a six-digit code that helps identify a company's primary business activity.

The NAICS code for Industrifonden is 523910, but it can also be classified under 523, 5239, 52, and 52391. This code is essential for various business purposes, such as government contracting and tax classification.

NAICS codes help businesses like Industrifonden to be classified correctly and accurately. This classification is crucial for government agencies, financial institutions, and other organizations to understand a company's industry and activities.

Industrifonden's NAICS code can be used to determine its business type and size, which can impact its tax obligations and government benefits.

The SIC code is a classification system used to identify the primary business activity of a company. Industrifonden has a SIC code of 679 and 67.

A SIC code can be important for businesses to determine their industry classification and for financial reporting purposes.

The SIC code for Industrifonden is a good example of how this classification system works.

Industrifonden is making a strategic move by strengthening its Life Science team with the recruitment of Patrik Sobocki as Investment Manager.

Patrik Sobocki joins Industrifonden with a rich background in the pharmaceutical industry, academic research, and startup development.

He previously held the position of European Chief Operating Officer for the business area Real World Evidence at IMS Health, the world's leading provider of information and technology services to the healthcare industry.

At Industrifonden, Patrik will bring his expertise to the table, no doubt making a significant impact on the team's investment strategies.

Industrifonden has a strategic partnership with Calliditas Therapeutics. They partnered on September 9, 2024.

Calliditas Therapeutics is a Swedish company. The partnership has been instrumental in the company's journey from a promising startup to a global leader in renal disease treatment.

Industrifonden celebrates the successful exit of Calliditas Therapeutics, which was acquired by Asahi Kasei.